In a phase III randomized clinical trial, patients with prostate cancer assigned to eat seven or more servings of vegetables and fruits daily saw no extra protection from the increased consumption of micronutrients.

Today, Ride for Roswell, presented by the West Herr Automotive Group, launched registration for this summer’s 25th anniversary event, taking place on Saturday, June 27. Online registration is available at RideforRoswell.org.

Promoting quality care for our patients and encouraging scientific innovation, Lijian Cai, PharmD, has joined the staff at Roswell Park Comprehensive Cancer Center as Senior Executive Director/Chief Pharmacy Officer.

In 2013, researchers from Roswell Park Comprehensive Cancer Center became one of the first teams to report that chronic stress can encourage the development and proliferation of tumor cells by suppressing natural immunity against cancer. In a new study published in the Journal of Clinical Investigation, the same laboratory has revealed an important and previously unknown means through which chronic stress weakens immunity against cancer

As Roswell Park Comprehensive Cancer Center continues to utilize the latest immunotherapies that spell hope for so many of our patients, BlueCross BlueShield of Western New York has recognized us as a Blue Distinction Center for Cellular Immunotherapy — CAR-T (chimeric antigen receptor). The center is one of two to receive this distinction in New York State.

Generous donations have set in motion eight groundbreaking new research projects at Roswell Park Comprehensive Cancer Center. The promising preliminary studies received a total of $772,330 from the Roswell Park Alliance Foundation, the 501(c)(3) not-for-profit organization that raises funds and manages all donations made to Roswell Park.

Breast cancer patients who take the dietary supplements known as antioxidants, as well as iron, vitamin B12, and omega-3 fatty acids, during chemotherapy may be at increased risk of disease recurrence and death, according to new study results appearing in the Journal of Clinical Oncology.